Rana K. Gupta

Rana Gupta has spent the last 12 years investing in and developing novel technologies. His passion for entrepreneurship is concentrated in entrepreneurial finance and technology development. Most recently, Mr. Gupta was CEO of HistoRx, a cancer diagnostics company and Yale University spin-out. He ran HistoRx for six years until selling it to Novartis AG in September 2012. Prior to HistoRx, Mr. Gupta was Managing Director at Navigator Technology Ventures (NTV), an early stage technology venture capital firm spun out of Draper Laboratory and based in Cambridge, MA. Six of NTV’s investments were laboratory or university spin-outs. Prior to his position with NTV, Mr. Gupta was Product Manager for Global Services with yet2.com, a B2B marketplace for technology transfer. Before yet2.com, Mr. Gupta founded IndoSine U.S. Link, Ltd., a business development company that helped clients expand international businesses between India, China, and the U.S. While running IndoSine, Mr Gupta co-founded a wireless software company, International Solutions, for which he served as Vice President of Sales and Marketing. Previous to IndoSine, he served as Manager, PRC Investment Strategy for Zeneca Pharmaceuticals in Beijing, China. At Zeneca, Mr Gupta was responsible for the China manufacturing strategy, for which he secured a $22M investment from the Board of Directors. For the last eight years, Mr Gupta has been teaching in BU’s entrepreneurship program in the areas of entrepreneurial finance and technology development. He holds an MBA in Finance and International Business from New York University's Stern School of Business, an MS in Operations Research from Stanford University, and a BA in Mathematics from Earlham College. More detalied information can be found here.